536 related articles for article (PubMed ID: 18657102)
1. Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer.
Howard K; Salkeld G
Value Health; 2009; 12(2):354-63. PubMed ID: 18657102
[TBL] [Abstract][Full Text] [Related]
2. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
[TBL] [Abstract][Full Text] [Related]
3. Measuring patient preferences for colorectal cancer screening using a choice-format survey.
Marshall DA; Johnson FR; Phillips KA; Marshall JK; Thabane L; Kulin NA
Value Health; 2007; 10(5):415-30. PubMed ID: 17888107
[TBL] [Abstract][Full Text] [Related]
4. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening.
de Bekker-Grob EW; Hol L; Donkers B; van Dam L; Habbema JD; van Leerdam ME; Kuipers EJ; Essink-Bot ML; Steyerberg EW
Value Health; 2010; 13(2):315-23. PubMed ID: 19912597
[TBL] [Abstract][Full Text] [Related]
5. Willingness to accept versus willingness to pay in a discrete choice experiment.
Grutters JP; Kessels AG; Dirksen CD; van Helvoort-Postulart D; Anteunis LJ; Joore MA
Value Health; 2008 Dec; 11(7):1110-9. PubMed ID: 18489505
[TBL] [Abstract][Full Text] [Related]
6. The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.
Benning TM; Dellaert BG; Severens JL; Dirksen CD
Value Health; 2014 Jul; 17(5):578-87. PubMed ID: 25128051
[TBL] [Abstract][Full Text] [Related]
7. Estimating willingness-to-pay for health care: A discrete choice experiment accounting for non-attendance to the cost attribute.
Sever I; Verbič M; Sever EK
J Eval Clin Pract; 2019 Oct; 25(5):843-849. PubMed ID: 30677196
[TBL] [Abstract][Full Text] [Related]
8. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
Marshall HS; Chen G; Clarke M; Ratcliffe J
Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249
[TBL] [Abstract][Full Text] [Related]
9. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
10. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
[TBL] [Abstract][Full Text] [Related]
11. An empirical comparison of methods for analyzing correlated data from a discrete choice survey to elicit patient preference for colorectal cancer screening.
Cheng J; Pullenayegum E; Marshall DA; Marshall JK; Thabane L
BMC Med Res Methodol; 2012 Feb; 12():15. PubMed ID: 22348526
[TBL] [Abstract][Full Text] [Related]
12. Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2].
Moro D; Schlander M; Telser H; Sola-Morales O; Clark MD; Olaye A; Camp C; Jain M; Butt T; Bakshi S
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):581-598. PubMed ID: 34877915
[TBL] [Abstract][Full Text] [Related]
13. Preferences for potential innovations in non-invasive colorectal cancer screening: A labeled discrete choice experiment for a Dutch screening campaign.
Benning TM; Dellaert BG; Dirksen CD; Severens JL
Acta Oncol; 2014 Jul; 53(7):898-908. PubMed ID: 24456499
[TBL] [Abstract][Full Text] [Related]
14. Assessing the value of symptom relief for patients with gastroesophageal reflux disease treatment: willingness to pay using a discrete choice experiment.
Deal K; Marshall D; Dabrowski D; Charter A; Bukoski M; Moayyedi P
Value Health; 2013 Jun; 16(4):588-98. PubMed ID: 23796293
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of patients' willingness to trade symptom-free days for asthma-related treatment risks: a discrete choice experiment.
McTaggart-Cowan HM; Shi P; Fitzgerald JM; Anis AH; Kopec JA; Bai TR; Soon JA; Lynd LD
J Asthma; 2008 Oct; 45(8):630-8. PubMed ID: 18951253
[TBL] [Abstract][Full Text] [Related]
16. Eliciting population preferences for mass colorectal cancer screening organization.
Nayaradou M; Berchi C; Dejardin O; Launoy G
Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
[TBL] [Abstract][Full Text] [Related]
17. Public preferences for counseling regarding antidepressant use during pregnancy: a discrete choice experiment.
Hancock-Howard RL; Ungar WJ; Marshall D; Einarson A; Koren G
Birth Defects Res A Clin Mol Teratol; 2012 Jul; 94(7):532-9. PubMed ID: 22730334
[TBL] [Abstract][Full Text] [Related]
18. Estimating Attribute-Specific Willingness-to-Pay Values from a Health Care Contingent Valuation Study: A Best-Worst Choice Approach.
Sever I; Verbič M; Klaric Sever E
Appl Health Econ Health Policy; 2020 Feb; 18(1):97-107. PubMed ID: 31562593
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
[TBL] [Abstract][Full Text] [Related]
20. The effect of including an opt-out option in discrete choice experiments.
Veldwijk J; Lambooij MS; de Bekker-Grob EW; Smit HA; de Wit GA
PLoS One; 2014; 9(11):e111805. PubMed ID: 25365169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
